Ahead of print
Research paper
Published online: 2020-09-02
Submitted: 2020-05-14
Accepted: 2020-08-10
Get Citation

Recanalisation of cerebral artery aneurysms treated endovascularly — a midterm follow-up

Witold Tomalski, Daniel Knap, Amadeusz Żak, Łukasz Binek, Milena Dewerenda- Sikora, Aleksandra Krzan, Przemysław Puz, Maciej Tomalski, Dominik Sieron, Wojciech Piwowarski, Wacław Kuczmik, Anetta Lasek-Bal
DOI: 10.5603/PJNNS.a2020.0065
·
Pubmed: 32875548

paid access

Ahead of print
Research paper
Published online: 2020-09-02
Submitted: 2020-05-14
Accepted: 2020-08-10

Abstract

Endovascular methods of aneurysm treatment, as an alternative to neurosurgical clipping, have proved a welcome opportunity to treat patients with unruptured aneurysms or those disqualified from neurosurgical intervention. This paper presents our own experience of endovascular treatment of cerebral aneurysms in 107 patients. It includes clinical and technical data from the perioperative period and a 12-month radiological follow-up of 78 patients. Method. Our retrospective evaluation covered patients with intracranial aneurysms treated endovascularly. The following were analysed: age, sex, neurological symptoms, and familial burden of intracranial aneurysm. Multivariate analysis was performed to determine independent factors of recanalisation of the cerebral aneurysm 12 months after embolisation. Results. The data of 107 patients at a mean age of 61 years [57.09 ± 14.27] treated with embolisation was analysed. The indication for intervention in 16 patients was subarachnoid haemorrhage; in the remaining 91 cases, aneurysms were revealed during diagnostic procedures for different symptoms or during imaging examinations. The intracranial segment of the internal carotid artery and the anterior communicating artery were the most common locations for aneurysms. After embolisation, subarachnoid haemorrhage occurred in one patient, ischaemic stroke in two patients, and one patient died because of acute circulatory insufficiency. The functional status of 94 patients on the day of discharge from the department (on days 4-21) was very good. 78 patients completed a 12-month follow-up period. In 11 of those, a follow-up MR angiography revealed recanalisation 12 months after the intervention. Except for one patient reporting vertigo, aneurysm recanalisation procedures were asymptomatic. The only independent risk factor for recanalisation was the size of aneurysm > 10 mm; OR 3.0; CI [1.15–7.83] p = 0.0255. Conclusions. Embolisation of cerebral aneurysms is a safe method with few perioperative complications, and most of these are mild and transient.The size of the aneurysm during qualification for embolisation is a risk factor for recanalisation in the subsequent 12 months. Recanalisation of embolised cerebral aneurysms concerns less than 20% of patients in a one-year follow-up and is most often asymptomatic.

Abstract

Endovascular methods of aneurysm treatment, as an alternative to neurosurgical clipping, have proved a welcome opportunity to treat patients with unruptured aneurysms or those disqualified from neurosurgical intervention. This paper presents our own experience of endovascular treatment of cerebral aneurysms in 107 patients. It includes clinical and technical data from the perioperative period and a 12-month radiological follow-up of 78 patients. Method. Our retrospective evaluation covered patients with intracranial aneurysms treated endovascularly. The following were analysed: age, sex, neurological symptoms, and familial burden of intracranial aneurysm. Multivariate analysis was performed to determine independent factors of recanalisation of the cerebral aneurysm 12 months after embolisation. Results. The data of 107 patients at a mean age of 61 years [57.09 ± 14.27] treated with embolisation was analysed. The indication for intervention in 16 patients was subarachnoid haemorrhage; in the remaining 91 cases, aneurysms were revealed during diagnostic procedures for different symptoms or during imaging examinations. The intracranial segment of the internal carotid artery and the anterior communicating artery were the most common locations for aneurysms. After embolisation, subarachnoid haemorrhage occurred in one patient, ischaemic stroke in two patients, and one patient died because of acute circulatory insufficiency. The functional status of 94 patients on the day of discharge from the department (on days 4-21) was very good. 78 patients completed a 12-month follow-up period. In 11 of those, a follow-up MR angiography revealed recanalisation 12 months after the intervention. Except for one patient reporting vertigo, aneurysm recanalisation procedures were asymptomatic. The only independent risk factor for recanalisation was the size of aneurysm > 10 mm; OR 3.0; CI [1.15–7.83] p = 0.0255. Conclusions. Embolisation of cerebral aneurysms is a safe method with few perioperative complications, and most of these are mild and transient.The size of the aneurysm during qualification for embolisation is a risk factor for recanalisation in the subsequent 12 months. Recanalisation of embolised cerebral aneurysms concerns less than 20% of patients in a one-year follow-up and is most often asymptomatic.

Get Citation

Keywords

cerebral aneurysm, embolisation, recanalisation

About this article
Title

Recanalisation of cerebral artery aneurysms treated endovascularly — a midterm follow-up

Journal

Neurologia i Neurochirurgia Polska

Issue

Ahead of print

Published online

2020-09-02

DOI

10.5603/PJNNS.a2020.0065

Pubmed

32875548

Keywords

cerebral aneurysm
embolisation
recanalisation

Authors

Witold Tomalski
Daniel Knap
Amadeusz Żak
Łukasz Binek
Milena Dewerenda- Sikora
Aleksandra Krzan
Przemysław Puz
Maciej Tomalski
Dominik Sieron
Wojciech Piwowarski
Wacław Kuczmik
Anetta Lasek-Bal

References (28)
  1. Connolly ES, Solomon RA. Management of unruptured aneurysms. Le Roux PD, Winn HR, Newell DW (Eds.). Management of Cerebral Aneurysms. Saunders, Philadelphia, Pa, USA. ; 2004: 271–285.
  2. Ajiboye N, Chalouhi N, Starke RM, et al. Unruptured Cerebral Aneurysms: Evaluation and Management. ScientificWorldJournal. 2015; 2015: 954954.
  3. Wiebers D. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. The Lancet. 2003; 362(9378): 103–110.
  4. Wakhloo AK, Lylyk P, de Vries J, et al. Surpass Study Group. Surpass flow diverter in the treatment of intracranial aneurysms: a prospective multicenter study. AJNR Am J Neuroradiol. 2015; 36(1): 98–107.
  5. Kiyosue H, Tanoue S, et al. Anatomic features predictive of complete aneurysm occlusion can be determined with three-dimensional digital subtraction angiography. American Journal of Neuroradiology. 2002; 23(7 ): 1206–1213.
  6. Tamatani S, Ito Y, Abe H, et al. Evaluation of the stability of aneurysms after embolization using detachable coils: correlation between stability of aneurysms and embolized volume of aneurysms. AJNR Am J Neuroradiol. 2002; 23(5): 762–767.
  7. Slob MJ, Sluzewski M, van Rooij WJ. The relation between packing and reopening in coiled intracranial aneurysms: a prospective study. Neuroradiology. 2005; 47(12): 942–945.
  8. Murayama Y, Nien YL, Duckwiler G, et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience. J Neurosurg. 2003; 98(5): 959–966.
  9. Alshekhlee A, Mehta S, Edgell RC, et al. Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm. Stroke. 2010; 41(7): 1471–1476.
  10. Jo KIl, Yeon JeY, Kim KHa, et al. Predictors of thromboembolism during coil embolization in patients with unruptured intracranial aneurysm. Acta Neurochir (Wien). 2013; 155(6): 1101–1106.
  11. Ihn YK, Shin SH, Baik SK, et al. Complications of endovascular treatment for intracranial aneurysms: Management and prevention. Interv Neuroradiol. 2018; 24(3): 237–245.
  12. McDonald JS, McDonald RJ, Fan J, et al. Comparative effectiveness of unruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling. Stroke. 2013; 44(4): 988–994.
  13. Naggara ON, Lecler A, Oppenheim C, et al. Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology. 2012; 263(3): 828–835.
  14. Spetzler RF, McDougall CG, Zabramski JM, et al. The Barrow Ruptured Aneurysm Trial. J Neurosurg. 2012; 116(1): 135–144.
  15. Spetzler RF, McDougall CG, Albuquerque FC, et al. The Barrow Ruptured Aneurysm Trial: 3-year results. J Neurosurg. 2013; 119(1): 146–157.
  16. Spetzler RF, McDougall CG, Zabramski JM, et al. The Barrow Ruptured Aneurysm Trial: 6-year results. J Neurosurg. 2015; 123(3): 609–617.
  17. Spetzler RF, McDougall CG, Zabramski JM, et al. Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial. J Neurosurg. 2019 [Epub ahead of print]: 1–6.
  18. Mooney M, Simon E, Brigeman S, et al. Long-term results of middle cerebral artery aneurysm clipping in the Barrow Ruptured Aneurysm Trial. Journal of Neurosurgery. 2019; 130(3): 895–901.
  19. Zhang Q, Jing L, Liu J, et al. Predisposing factors for recanalization of cerebral aneurysms after endovascular embolization: a multivariate study. J Neurointerv Surg. 2018; 10(3): 252–257.
  20. Jeon JP, Cho YD, Rhim JK, et al. Extended monitoring of coiled aneurysms completely occluded at 6-month follow-up: late recanalization rate and related risk factors. Eur Radiol. 2016; 26(10): 3319–3326.
  21. Lecler A, Raymond J, Rodriguez-Régent C, et al. Intracranial Aneurysms: Recurrences More than 10 Years after Endovascular Treatment-A Prospective Cohort Study, Systematic Review, and Meta-Analysis. Radiology. 2015; 277(1): 173–180.
  22. Sugiyama SI, Niizuma K, Sato K, et al. Blood Flow Into Basilar Tip Aneurysms: A Predictor for Recanalization After Coil Embolization. Stroke. 2016; 47(10): 2541–2547.
  23. Li C, Wang S, Chen J, et al. Influence of hemodynamics on recanalization of totally occluded intracranial aneurysms: a patient-specific computational fluid dynamic simulation study. J Neurosurg. 2012; 117(2): 276–283.
  24. Gruszka W, Zbroszczyk M, Komenda J, et al. The role of inflammation and potential pharmacological therapy in intracranial aneurysms. Neurol Neurochir Pol. 2018; 52(6): 662–669.
  25. Nastasovic T, Milakovic B, Stosic M, et al. Predictors of unfavourable outcome in aneurysmal subarachnoid haemorrhage. Neurol Neurochir Pol. 2019; 53(6): 421–427.
  26. Yeon EK, Cho YD, Yoo DH, et al. Delayed Progression to Major Recanalization in Coiled Aneurysms with Minor Recanalization at 36-Month Follow-up : Incidence and Related Risk Factors. Clin Neuroradiol. 2020 [Epub ahead of print].
  27. Tailor J, Goetz P, Chandrashekar H, et al. Stability of ruptured intracranial aneurysms treated with detachable coils: is delayed follow-up angiography warranted? Br J Neurosurg. 2010; 24(4): 405–409.
  28. Raymond J, Guilbert F, Weill A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003; 34(6): 1398–1403.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl